Related Articles
R-etodolac induces E-cadherin and suppresses colitis-related mouse colon tumorigenesis
Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium
Chronic colitis promotes tumor development
Geranylgeranylacetone suppresses colitis‑related mouse colon carcinogenesis
Etodolac, a selective cyclooxygenase-2 inhibitor, induces apoptosis by activating caspases in human malignant rhabdoid tumor cells (FRTK-1)